🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,99 USD

Máx. histórico

178,74

2143 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,38%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+2,43%

Cierre anterior

18,54

Rango de hoy

18,52 – 19,26

Volumen hoy

1.328.200

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 23 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/11/2022 109,72 112,12 108,91 111,98 +1,29% 2,93% 902.600
21/11/2022 112,00 113,05 110,09 110,55 -1,29% 2,64% 442.000
18/11/2022 111,13 113,09 110,49 112,00 +1,86% 2,34% 847.500
17/11/2022 108,52 110,54 107,81 109,96 +0,63% 2,52% 398.700
16/11/2022 109,88 110,89 107,51 109,27 -0,37% 3,08% 754.700
15/11/2022 110,00 110,49 108,25 109,68 +1,34% 2,04% 818.400
14/11/2022 107,51 109,41 106,05 108,23 +1,24% 3,13% 835.600
11/11/2022 105,96 107,98 103,96 106,90 +0,02% 3,79% 781.000
10/11/2022 107,72 108,22 105,08 106,88 +2,83% 2,91% 1.115.300
09/11/2022 105,22 105,75 103,24 103,94 -1,16% 2,39% 865.200
08/11/2022 100,39 107,96 100,39 105,16 +4,75% 7,54% 1.532.300
07/11/2022 103,18 104,20 100,21 100,39 -3,13% 3,87% 905.400
04/11/2022 105,01 105,79 100,15 103,63 -1,31% 5,37% 1.252.000
03/11/2022 106,89 111,75 102,03 105,01 -7,41% 9,09% 2.410.200
02/11/2022 113,51 117,49 112,02 113,42 -0,58% 4,82% 775.000
01/11/2022 114,92 116,95 113,72 114,08 +0,05% 2,81% 572.400
31/10/2022 114,36 116,41 113,46 114,02 -1,09% 2,58% 972.800
28/10/2022 111,90 115,85 111,27 115,28 +3,17% 4,09% 1.024.700
27/10/2022 114,79 116,00 111,17 111,74 -2,25% 4,21% 1.111.400
26/10/2022 112,44 116,16 111,86 114,31 +1,97% 3,82% 934.800
25/10/2022 110,73 113,73 110,73 112,10 +1,36% 2,71% 914.300
24/10/2022 113,05 113,75 108,22 110,60 -1,86% 4,89% 997.300
21/10/2022 112,86 114,32 111,32 112,70 +0,53% 2,66% 1.202.600
20/10/2022 112,93 113,84 111,20 112,11 -0,12% 2,34% 871.200
19/10/2022 116,32 117,99 110,23 112,25 -3,92% 6,67% 1.374.100
18/10/2022 115,72 118,75 115,72 116,83 +2,12% 2,62% 1.210.900
17/10/2022 114,77 116,98 112,94 114,41 +1,74% 3,52% 988.100
14/10/2022 114,00 114,96 110,83 112,45 -0,46% 3,62% 829.000
13/10/2022 109,10 113,75 106,39 112,97 +0,75% 6,75% 1.173.800
12/10/2022 109,45 112,57 107,98 112,13 +2,89% 4,19% 1.033.600